Vireo Growth (VREOF) Shares Outstanding (Diluted Average) (2020 - 2026)

Vireo Growth's (VREOF) quarterly Shares Outstanding (Diluted Average) came in at $1.1 billion in Q1 2026, up 194.56% year-on-year from $366.8 million in Q1 2025, and up 47.05% quarter-over-quarter from $734.7 million in Q4 2025.

Vireo Growth (VREOF) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $1.1 billion for Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $1.1 billion, up 194.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 194.56% YoY), and the FY2025 annual result was $734.7 million, up 307.3% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $1.1 billion for Q1 2026 at Vireo Growth, up from $734.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.1 billion in Q1 2026 to a low of $128.1 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $143.1 million (2024), against an average of $296.7 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) grew 0.01% in 2023 and jumped 307.3% in 2025, its largest moves.
  • Vireo Growth's Shares Outstanding (Diluted Average) stood at $128.1 million in 2022, then gained by 5.55% to $135.2 million in 2023, then jumped by 33.39% to $180.4 million in 2024, then jumped by 307.3% to $734.7 million in 2025, then surged by 47.05% to $1.1 billion in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $1.1 billion (Q1 2026), $734.7 million (Q4 2025), and $627.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Vireo Growth - - 59.30 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Bn
Dec 31, 2025 734.74 Mn
Sep 30, 2025 627.65 Mn
Jun 30, 2025 559.10 Mn
Mar 31, 2025 366.80 Mn
Dec 31, 2024 180.39 Mn
Sep 30, 2024 162.84 Mn
Jun 30, 2024 143.58 Mn
Mar 31, 2024 143.13 Mn
Dec 31, 2023 135.24 Mn
Sep 30, 2023 141.33 Mn
Jun 30, 2023 128.13 Mn
Mar 31, 2023 128.13 Mn
Dec 31, 2022 128.13 Mn
Sep 30, 2022 128.11 Mn
Jun 30, 2022 128.11 Mn
Mar 31, 2022 128.11 Mn
Dec 31, 2021 123.81 Mn
Sep 30, 2021 122.70 Mn
Jun 30, 2021 125.56 Mn